Placebo-Controlled Study in Patients With Coronary Artery Disease : A Randomized, Double-Blind, Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor
نویسندگان
چکیده
Christian Seiler, Tilmann Pohl, Kerstin Wustmann, Damian Hutter, Pierre-Alain Nicolet, Placebo-Controlled Study in Patients With Coronary Artery Disease : A Randomized, Double-Blind, Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2001 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/hc4201.097835 2001;104:2012-2017 Circulation. http://circ.ahajournals.org/content/104/17/2012 World Wide Web at: The online version of this article, along with updated information and services, is located on the
منابع مشابه
Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.
BACKGROUND Experimentally, activated macrophages have been documented to induce vascular proliferation. METHODS AND RESULTS In 21 patients (age 74+/-9 years) with extensive coronary artery disease not eligible for coronary artery bypass surgery, the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF, Molgramostim) on quantitatively assessed collateral flow was tested in a rand...
متن کاملSTART Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.
BACKGROUND Granulocyte-macrophage colony-stimulating factor (GM-CSF) was recently shown to increase collateral flow index in patients with coronary artery disease. Experimental models showed beneficial effects of GM-CSF on collateral artery growth in the peripheral circulation. Thus, in the present study, we evaluated the effects of GM-CSF in patients with peripheral artery disease. METHODS A...
متن کاملMyocardial salvage through coronary collateral growth by granulocyte colony-stimulating factor in chronic coronary artery disease: a controlled randomized trial.
BACKGROUND The efficacy of granulocyte colony-stimulating factor (G-CSF) for coronary collateral growth promotion and thus impending myocardial salvage has not been studied so far, to our best knowledge. METHODS AND RESULTS In 52 patients with chronic stable coronary artery disease, age 62+/-11 years, the effect on a marker of myocardial infarct size (ECG ST segment elevation) and on quantita...
متن کاملPromotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease.
Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease To the Editor: The study by Seiler et al1 on collateral growth stimulation in humans by granulocyte-macrophage colony-stimulating factor (GM-CSF) received a very optimistic editorial by Schaper.2 The authors should be congratulated on the study concept and the conduct of this first-time approach to assess ...
متن کاملThe Efficacy of Therapeutic Angiogenesis Using basic Fibroblast Growth Factor in Patients with Coronary Artery Disease: A Double-Blind, Placebo-Controlled Study
Background and Objectives: Complete revascularization is not possible in up to 37% of patients with coronary artery disease (CAD). Therapeutic angiogenesis may be considered as an option in the management of these patients. The aim of the present study was to evaluate the effectiveness and safety of therapeutic angiogenesis using basic fibroblast growth factor in patients with ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2001